School of Women's and Children's Health, UNSW Medicine, Sydney, Australia.
The George Institute for Global Health, Beijing, China.
Reprod Health. 2021 Jun 26;18(1):133. doi: 10.1186/s12978-021-01180-1.
Gestational diabetes (GDM) is a global problem affecting millions of pregnant women, including in mainland China. These women are at high risk of Type II diabetes (T2DM). Cost-effective and clinically effective interventions are needed. We aimed to explore Chinese women's perspectives, concerns and motivations towards participation in early postpartum interventions and/or research to prevent the development of T2DM after a GDM-affected pregnancy.
We conducted a qualitative study in two hospitals in Chengdu, Southwest China. Face-to-face semi-structured interviews were conducted with 20 women with recent experience of GDM: 16 postpartum women and 4 pregnant women. Women were asked about their attitudes towards postpartum screening for type 2 diabetes, lifestyle interventions, mHealth delivered interventions and pharmacologic interventions (specifically metformin). An inductive approach to analysis was used. Interviews were recorded, transcribed, and coded using NVivo 12 Pro.
Most women held positive attitudes towards participating in T2DM screening, and were willing to participate in postpartum interventions to prevent T2DM through lifestyle change or mHealth interventions. Women were less likely to agree to pharmacological intervention, unless they had family members with diabetes or needed medication themselves during pregnancy. We identified seven domains influencing women's attitudes towards future interventions: (1) experiences with the health system during pregnancy; (2) living in an enabling environment; (3) the experience of T2DM in family members; (4) knowledge of diabetes and perception of risk; (5) concerns about personal and baby health; (6) feelings and emotions, and (7) lifestyle constraints. Those with more severe GDM, an enabling environment and health knowledge, and with experience of T2DM in family members expressed more favourable views of postpartum interventions and research participation to prevent T2DM after GDM. Those who perceived themselves as having mild GDM and those with time/lifestyle constraints were less likely to participate.
Women with experiences of GDM in Chengdu are generally willing to participate in early postpartum interventions and/or research to reduce their risk of T2DM, with a preference for non-drug, mHealth based interventions, integrating lifestyle change strategies, blood glucose monitoring, postpartum recovery and mental health.
妊娠糖尿病(GDM)是一个全球性问题,影响着数以百万计的孕妇,包括中国内地的孕妇。这些女性患 2 型糖尿病(T2DM)的风险很高。需要经济有效的、具有临床效果的干预措施。我们旨在探索中国女性对参与产后早期干预和/或研究以预防 GDM 后 T2DM 发展的看法、关注和动机。
我们在中国西南部成都市的两家医院进行了一项定性研究。对 20 名近期患有 GDM 的女性(16 名产后女性和 4 名孕妇)进行了面对面的半结构式访谈。询问女性对产后 2 型糖尿病筛查、生活方式干预、移动医疗(mHealth)干预和药物干预(具体为二甲双胍)的态度。采用归纳法进行分析。使用 NVivo 12 Pro 对访谈进行记录、转录和编码。
大多数女性对参与 T2DM 筛查持积极态度,并愿意通过生活方式改变或 mHealth 干预来参与产后干预以预防 T2DM。除非她们有糖尿病家族成员或在怀孕期间需要药物治疗,否则她们不太可能同意药物干预。我们确定了影响女性对未来干预措施态度的七个领域:(1)怀孕期间对医疗系统的体验;(2)生活在有利的环境中;(3)家庭成员患 T2DM 的经历;(4)对糖尿病的认识和对风险的感知;(5)对个人和婴儿健康的关注;(6)感觉和情绪;(7)生活方式限制。那些患有更严重 GDM、有利环境和健康知识、且有家族成员 T2DM 经历的人,对 GDM 后预防 T2DM 的产后干预和研究参与表示更为有利的看法。那些认为自己患有轻度 GDM 的人和那些有时间/生活方式限制的人不太可能参与。
成都有 GDM 经历的女性通常愿意参与产后早期干预和/或研究,以降低患 T2DM 的风险,她们更喜欢非药物、基于 mHealth 的干预措施,整合生活方式改变策略、血糖监测、产后恢复和心理健康。